Dr. Geesaman joined the X PRIZE Foundation from MPM Capital, where he worked as a Venture Partner, assessing new investment opportunities and assisting in business development for existing portfolio companies. At MPM he founded JapanBridge, an oncology pharmaceutical company in Tokyo which focuses on expediting drug development in Asia. Prior to MPM, he served as the Vice President, Medical Development for Elixir Pharmaceuticals, where he oversaw clinical strategy for drug development and the human genetics program, as well being involved in the company’s business development team. Coincident with these activities, Dr. Geesaman was a General Partner at F2 Ventures, a UK based venture capital fund, and he continues to serve on the board of directors for these investments. His first experience in business immediately followed his medical training; Dr. Geesaman founded and was Chief Technical Officer of Catalyst Medical Solutions, where he designed and coded an enterprise application to enhance hospital revenue and improve medical documentation and compliance.

Dr. Geesaman’s academic background ranges from the fields of computer engineering to computational biology to clinical medicine, and he has written for a number of publications in these fields. Dr. Geesaman became board certified in Internal Medicine in 2000, after completing a Clinical Fellowship at the Massachusetts General Hospital. He has a PhD in Systems and Computational Neurobiology from MIT, an M.D. from Harvard Medical School and a B.S. from U.C. Berkeley in Systems Neurobiology.